Sarah Elizabeth Richards, The Washington Post | Sunday May 19, 2019
Compared to other cancer success stories, ovarian cancer historically has had a shortage of good news. It is deadlier and underfunded. Until recently, the disease has not benefited from new treatments for more than 40 years.
doctor.ndtv.com